DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Nelson DR, Cooper JN editor LB3;
All-oral 12-week combination treatment with daclatasvir (DCV) and sofosbuvir (SOF) in patients infected with HCV genotype 3: ALLY-3 Phase 3 study.
AASLD 2014; 2014
Boston:
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.